SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GFIH Graham-Field Health Prod

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron logo who wrote (48)10/24/1998 2:01:00 AM
From: Steve Rolfe  Read Replies (2) of 84
 
Good revenue increases qtr to qtr. Did not absorb acquisitions well. Need to reduce debt. Big disappointment a couple of quarters ago when it became apparent that the transition of the acquired companies was a struggle. I watched the stock go from 4 to 17 down to 2. Good buyout target. Big question: Can they keep the debt in check until they get the operating issues from the acquisitions ironed out. If so, they have some powerful revenue numbers for a stock trading in the 2's. Gotta make money though - they were on track until one of the last acquisitions. If they can't make it - the creditors will get their money first so there is a risk there. Looks positive to me though. The 45,000 share purchase says someone thinks they are ready to get their house in order. Creeping up through the 2's nicely. Just my opinion - read the last few financial statements to form your own.

Steve Rolfe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext